Search results
FDA approves bladder cancer treatment by Culver City company
LA Times via Yahoo News· 5 days agoThe Food and Drug Administration has approved Culver City-based ImmunityBio's treatment for bladder...
FDA Approves New Bladder Cancer Drug
Medscape· 5 days agoThe first-in-class agent is approved alongside bacillus Calmette-Guérin to treat certain non–muscle-invasive bladder cancers that do not respond to...
4 FAQs About Anesthesia for Bladder Botox
Healthline· 4 days agoBladder Botox injections are typically done under local anesthetic, though you also have the option to undergo the procedure with a general anesthetic....
Drug for Overactive Bladder Recommended in Europe
Medscape· 2 days agoObgemsa is suitable for treating symptoms of an overactive bladder in adults, the European Medicines Agency has determined.
Millions of people suffer with overactive bladder or OAB, but few talk about it
KTVK 3TV Phoenix· 5 days agoThe following content is created on behalf of Bladder Centers of America and does not reflect the...
British patients test world’s first personalised mRNA jab for melanoma
Press Association News via AOL· 2 days agoThe world’s first personalised mRNA cancer jab for melanoma – which also has the potential to stop...
Who Is Josh Bowling? Abby Hensel’s Husband Details
In Touch Weekly· 2 days agoConjoined twin Abby Hensel quietly married her husband, Josh Bowling, more than two years ago and fans are curious about the details of her new partner....
Immunotherapy Combination Approved for Non-Muscle Invasive Bladder Cancer
Technology Networks· 4 days agoThe decision was based on results of the QUILT 3.032 clinical trial, which was led by Dr. Karim...
MS patients 'too embarrassed' to speak to doctors about some symptoms
dpa international via Yahoo News· 5 days agoMore than a third of patients living with multiple sclerosis (MS) in the UK have avoided seeking...
... Approval of ANKTIVA®, First-in-Class IL-15 Receptor Agonist for BCG-Unresponsive Non-Muscle...
Morningstar· 5 days agoImmunityBio Announces FDA Approval of ANKTIVA®, First-in-Class IL-15 Receptor Agonist for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer Designated an FDA Breakthrough ...
